A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma
- 30 April 2004
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 93 (1), 34-40
- https://doi.org/10.1016/j.ygyno.2003.12.038
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Immunohistochemical Profile of Endometrial Adenocarcinoma: A Study of 61 Cases and Review of the LiteratureLaboratory Investigation, 2000
- Immunohistochemical Analysis of Endometrial Adenocarcinoma for bcl-2 and p53 in Relation to Expression of Sex Steroid Receptor and Proliferative ActivityInternational Journal of Gynecological Pathology, 1996
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- An immunohistochemical study of estrogen and progesterone receptors in adenocarcinoma of the endometrium and in the adjacent mucosaInternational Journal of Gynecologic Cancer, 1995
- Proliferative activity as revealed by Ki-67 in uterine adenocarcinoma of endometrioid type: Comparison of tumours from patients with and without previous oestrogen therapyThe Journal of Pathology, 1993
- Oestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods.Journal of Clinical Pathology, 1992
- Estrogen and progesterone receptors in endometrial cancer and their prognostic relevanceGynecologic Oncology, 1990
- Oestrogen and Progestin Receptors as Prognostic Indicators in Endometrial Cancer: A review of the literatureActa Oncologica, 1989
- Cell cycle dependent distribution of the proliferation-associated Ki-67 antigen in human embryonic lung cellsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1988
- The distribution and prognostic implications of steroid receptors in endometrial carcinomasGynecologic Oncology, 1987